Vectura Group

Related Companies

• Lonza
• Hermes Pharma GmbH
• GEA Pharma and Healthcare
• Titan Enterprises
• Actylis – The Partner of Choice
• ProtaGene
• Qualicaps
• Austar
• Asynt
• LB Bohle
• Vetter Pharma International
• Starlab
• Gerresheimer
• Romaco Holding GmbH
• Vectorbuilder Inc
• Innopharma Technology
• Butterworth Laboratories
• DWK Life Sciences
• Indena
• Nanoform

Related Content

Vectura’s $62.7m inhalation centre granted planning permission

Optimising dry powder inhaler programmes through formulation

Vectura to provide development services for brain injury drug

Free webcast: Inhaled Bioequivalence - A Broader View of Product Development

Accelerating excipient development for inhalable dosage forms with QbD

Vectura expanding manufacturing capabilities in Chippenham

Vectura earns $11m milestone with Hikma generic launch

Vectura expands HPAPI capabilities in the UK

Vectura signs agreement with Kinaset to develop asthma treatment

Status update on ANDA for generic Advair Diskus (VR315 [US])

Vectura partners with Monash University on inhaled oxytocin

Delivering success for inhaled drug development programmes

Vectura Group names new Chief Commercial Officer

Opening the aperture: taking a wider view of the inhalables market

Hikma announces agreement with Vectura to develop generic salmeterol for the US market